Based on the PPI network analysis and four algorithms in Cytoscape software, STAT3, JUN, MAPK3, TP53, MAPK1, RELA, FOS, ESR1, IL6, MAPK14, MYC, and CDKN1A were identified as hub targets in the treatment of CRC. The gene discussed is FOS; the disease is colorectal carcinoma.